Evidence map›Paper›PMID 37735975›Full record

ArticleMolecular systems biology2023

Modeling unveils sex differences of signaling networks in mouse embryonic stem cells.

Zeba Sultana, Mathurin Dorel, Bertram Klinger, Anja Sieber, Ilona Dunkel, Nils Blüthgen, Edda G Schulz

Open access · goldAbstract read
In one paragraph

Article in Molecular systems biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zeba SultanaSystems Epigenetics, Otto-Warburg-Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Mathurin DorelComputational Modelling in Medicine, Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Bertram KlingerComputational Modelling in Medicine, Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-0242-1506
Anja SieberComputational Modelling in Medicine, Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-6588-8547
Ilona DunkelSystems Epigenetics, Otto-Warburg-Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Nils BlüthgenComputational Modelling in Medicine, Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-0171-7447
Edda G SchulzSystems Epigenetics, Otto-Warburg-Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0003-1253-6868
Charité - Universitätsmedizin Berlin · DEMax Planck Institute for Molecular Genetics · DE

Funding

Bundesministerium für Bildung und Forschung (BMBF) BMBF 031 L0072Deutsche Forschungsgemeinschaft (DFG) GRK1772Human Frontier Science Program (HFSP) CDA-00064/2018Max Planck Research Group Leader Program
6 · The paper itself

Abstract

For a short period during early development of mammalian embryos, both X chromosomes in females are active, before dosage compensation is ensured through X-chromosome inactivation. In female mouse embryonic stem cells (mESCs), which carry two active X chromosomes, increased X-dosage affects cell signaling and impairs differentiation. The underlying mechanisms, however, remain poorly understood. To dissect X-dosage effects on the signaling network in mESCs, we combine systematic perturbation experiments with mathematical modeling. We quantify the response to a variety of inhibitors and growth factors for cells with one (XO) or two X chromosomes (XX). We then build models of the signaling networks in XX and XO cells through a semi-quantitative modeling approach based on modular response analysis. We identify a novel negative feedback in the PI3K/AKT pathway through GSK3. Moreover, the presence of a single active X makes mESCs more sensitive to the differentiation-promoting Activin A signal and leads to a stronger RAF1-mediated negative feedback in the FGF-triggered MAPK pathway. The differential response to these differentiation-promoting pathways can explain the impaired differentiation propensity of female mESCs.

Indexed as

Embryonic Stem CellsMouse Embryonic Stem CellsAnimalsCell DifferentiationFemaleGlycogen Synthase Kinase 3MaleMammalsMicePhosphatidylinositol 3-KinasesSex CharacteristicsSignal TransductionGlycogen Synthase Kinase 3Phosphatidylinositol 3-Kinasescell signalingmathematical modelingpluripotencystem cellsX chromosomeX-chromosome inactivation

Identifiers

PMID37735975
PMCPMC10632733
OpenAlexW4386945159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.